CoChat

Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis

Open access

Published version of a preprint

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Previous reports on the associations between COVID-19 and gut microbiome have been constrained by taxonomic-level analysis and overlook the interaction between microbes. By applying a genome-resolved, reference-free, guild-based metagenomic analysis, we demonstrated that the relationship between gut microbiota and COVID-19 is genome-specific instead of taxon-specific or even species-specific.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.03519-22

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 The overall structural variations of gut microbiota at admission are associated with disease severity in hospitalized COVID-19 patients. (A) Principal coordinate analysis (PCoA) based on Bray-Curtis calculated from abundance of the 2,568 genomes. (B) and (C) Comparison of the PC1 and PC2. (D) Comparison of alpha-diversity as indicated by Shannon index. Boxes show medians and interquartile ranges (IQRs); whiskers denote the lowest and highest values that were within 1.5× the IQR from the first and third quartiles, outliers are shown as individual points. Kruskal-Wallis test followed by Dunn’s post hoc test (two-sided) was used to compare groups. Compact letters indicate the significance of the post hoc test (P < 0.05 is significant). Mild, n = 88; moderate, n = 196; severe/critical, n = 12.
FIG 1 The overall structural variations of gut microbiota at admission are associated with disease severity in hospitalized COVID-19 patients. (A) Principal coordinate analysis (PCoA) based on Bray-Curtis calculated from abundance of the 2,568 genomes. (B) and (C) Comparison of the PC1 and PC2. (D) Comparison of alpha-diversity as indicated by Shannon index. Boxes show medians and interquartile ranges (IQRs); whiskers denote the lowest and highest values that were within 1.5× the IQR from the first and third quartiles, outliers are shown as individual points. Kruskal-Wallis test followed by Dunn’s post hoc test (two-sided) was used to compare groups. Compact letters indicate the significance of the post hoc test (P < 0.05 is significant). Mild, n = 88; moderate, n = 196; severe/critical, n = 12.CC BY · PubMed Central
FIG 2 Two competing guilds composed of differentially abundant gut microbial genomes are associated with symptom severity in COVID-19 patients. (A) Heatmap of 33 high-quality metagenome-assembled genomes (HQMAGs) identified by redundancy analysis (RDA) and showing differences between the 3 severity groups. RDA analysis was conducted based on the Hellinger transformed abundance of all HQMAGs and used three symptom severity groups as environmental variables. HQMAGs with at least 5% of the variability in their abundance explained by constrained axes were selected. A Kruskal-Wallis test followed by Dunn’s post hoc test (two-sided) was used to test the differences between the 3 severity groups. Compact letters indicate the significance of the post hoc test (P < 0.05 is significant). Heatmap shows the mean abundance of each HQMAGs in each group. Abundance was scaled across each row. (B) Co-abundance network of the HQMAGs reflects two competing guilds. The co-abundance correlation between the HQMAGs were calculated using Fastspar (n = 296 subject). All significant correlations with Benjamini-Hochberg (BH)-adjusted P < 0.05 were included. Edges between nodes represent correlations. Red and blue colors indicate positive and negative correlations, respectively. Node size indicates the average abundance of the HQMAGs in 296 samples. Genomes were clustered into two guilds based on co-abundance correlation and complete linkage followed by weighted correlation network analysis (WGCNA) analysis. Node color indicates guild: Guild 1, orange; Guild 2, purple. (C) Comparison of guild-level microbiome index (GMI). Data points which do not share common compact letters are significantly different from each other (P < 0.05). Boxes show medians and IQRs; whiskers denote the lowest and highest values that lie within 1.5× the IQR from the first and third quartiles, outliers are shown as individual points. A Kruskal-Wallis test followed by Dunn’s post hoc test (two-sided) was applied to compare the groups. Compact letters indicate the significance of the test (P < 0.05). Mild, n = 88; moderate, n = 196; severe/critical, n = 12. (D) GMI supports classification of different COVID-19 symptom severities. AUROC (area under the receiver operating characteristic curve) is shown.
FIG 2 Two competing guilds composed of differentially abundant gut microbial genomes are associated with symptom severity in COVID-19 patients. (A) Heatmap of 33 high-quality metagenome-assembled genomes (HQMAGs) identified by redundancy analysis (RDA) and showing differences between the 3 severity groups. RDA analysis was conducted based on the Hellinger transformed abundance of all HQMAGs and used three symptom severity groups as environmental variables. HQMAGs with at least 5% of the variability in their abundance explained by constrained axes were selected. A Kruskal-Wallis test followed by Dunn’s post hoc test (two-sided) was used to test the differences between the 3 severity groups. Compact letters indicate the significance of the post hoc test (P < 0.05 is significant). Heatmap shows the mean abundance of each HQMAGs in each group. Abundance was scaled across each row. (B) Co-abundance network of the HQMAGs reflects two competing guilds. The co-abundance correlation between the HQMAGs were calculated using Fastspar (n = 296 subject). All significant correlations with Benjamini-Hochberg (BH)-adjusted P < 0.05 were included. Edges between nodes represent correlations. Red and blue colors indicate positive and negative correlations, respectively. Node size indicates the average abundance of the HQMAGs in 296 samples. Genomes were clustered into two guilds based on co-abundance correlation and complete linkage followed by weighted correlation network analysis (WGCNA) analysis. Node color indicates guild: Guild 1, orange; Guild 2, purple. (C) Comparison of guild-level microbiome index (GMI). Data points which do not share common compact letters are significantly different from each other (P < 0.05). Boxes show medians and IQRs; whiskers denote the lowest and highest values that lie within 1.5× the IQR from the first and third quartiles, outliers are shown as individual points. A Kruskal-Wallis test followed by Dunn’s post hoc test (two-sided) was applied to compare the groups. Compact letters indicate the significance of the test (P < 0.05). Mild, n = 88; moderate, n = 196; severe/critical, n = 12. (D) GMI supports classification of different COVID-19 symptom severities. AUROC (area under the receiver operating characteristic curve) is shown.CC BY · PubMed Central
FIG 3 The two competing guilds at admission are associated with COVID-19 severity in hospitalized patients on day 7 after admission and with endpoint in critical patients. (A) Bar plot shows the correlations between the GMI at admission and clinical parameters of COVID-19 in hospitalized patients on day 7. Age-adjusted partial Spearman’s correlation was calculated. Correlations with BH-adjusted P < 0.1 are shown. Blue bar, biochemical indicators; green bar, coagulation indicators; red bar, immune indicators. (B) GMI at admission associated with death/discharge outcomes of critical COVID-19 patients. A two-sided Mann-Whitney test was used to determine significance. *, P < 0.05. Death, n = 3; discharge, n = 4.
FIG 3 The two competing guilds at admission are associated with COVID-19 severity in hospitalized patients on day 7 after admission and with endpoint in critical patients. (A) Bar plot shows the correlations between the GMI at admission and clinical parameters of COVID-19 in hospitalized patients on day 7. Age-adjusted partial Spearman’s correlation was calculated. Correlations with BH-adjusted P < 0.1 are shown. Blue bar, biochemical indicators; green bar, coagulation indicators; red bar, immune indicators. (B) GMI at admission associated with death/discharge outcomes of critical COVID-19 patients. A two-sided Mann-Whitney test was used to determine significance. *, P < 0.05. Death, n = 3; discharge, n = 4.CC BY · PubMed Central
FIG 4 Genome-based microbiome signature enables classification of COVID-19 patients from different severity groups in an independent Chinese cohort. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 HQMAGs. Permutational multivariate analysis of variance (PERMANOVA) test showed significant differences in the composition of the 33 HQMAGs between the two groups. (B) Significant differences in GMI and abundances of guilds 1 and 2 between mild/moderate and severe/critical COVID-19 patients. Bar plot summarizes the mean and standard error of the mean (SEM). Mann-Whitney test (two-sided) was used to compare groups. Mild/moderate, n = 24; severe/critical, n = 14. **, P < 0.01; *, P < 0.05. (C) GMI supports classification according to different COVID-19 symptom severities.
FIG 4 Genome-based microbiome signature enables classification of COVID-19 patients from different severity groups in an independent Chinese cohort. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 HQMAGs. Permutational multivariate analysis of variance (PERMANOVA) test showed significant differences in the composition of the 33 HQMAGs between the two groups. (B) Significant differences in GMI and abundances of guilds 1 and 2 between mild/moderate and severe/critical COVID-19 patients. Bar plot summarizes the mean and standard error of the mean (SEM). Mann-Whitney test (two-sided) was used to compare groups. Mild/moderate, n = 24; severe/critical, n = 14. **, P < 0.01; *, P < 0.05. (C) GMI supports classification according to different COVID-19 symptom severities.CC BY · PubMed Central
FIG 5 Genome-based microbiome signature enables classification of COVID-19 patients from different severity groups in an independent American cohort. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 HQMAGs. PERMANOVA test showed significant differences in the composition of the 33 HQMAGs between the two groups. (B) Significant differences in GMI and abundances of guilds 1 and 2 between moderate and severe COVID-19 patients. Bar plot summarizes mean and SEM. Mann-Whitney test (two-sided) was applied to compare groups. Moderate, n = 18; severe, n = 9. ***, P < 0.001; **, P < 0.01. (C) GMI supports classification according to different COVID-19 symptom severities.
FIG 5 Genome-based microbiome signature enables classification of COVID-19 patients from different severity groups in an independent American cohort. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 HQMAGs. PERMANOVA test showed significant differences in the composition of the 33 HQMAGs between the two groups. (B) Significant differences in GMI and abundances of guilds 1 and 2 between moderate and severe COVID-19 patients. Bar plot summarizes mean and SEM. Mann-Whitney test (two-sided) was applied to compare groups. Moderate, n = 18; severe, n = 9. ***, P < 0.001; **, P < 0.01. (C) GMI supports classification according to different COVID-19 symptom severities.CC BY · PubMed Central
FIG 6 Genome-based microbiome signature enabled distinction between COVID-19 and pneumonia subjects in an independent data set. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 HQMAGs. (B) Significant differences in GMI and abundances of guilds 1 and 2 between COVID-19 and pneumonia subjects. Bar plot summarizes the mean and SEM. Mann-Whitney test (two-sided) was applied to compare groups. COVID-19, n = 66; pneumonia, n = 9. **, P < 0.01; *, P < 0.05. (C) GMI supports classification between COVID-19 and pneumonia control group.
FIG 6 Genome-based microbiome signature enabled distinction between COVID-19 and pneumonia subjects in an independent data set. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 HQMAGs. (B) Significant differences in GMI and abundances of guilds 1 and 2 between COVID-19 and pneumonia subjects. Bar plot summarizes the mean and SEM. Mann-Whitney test (two-sided) was applied to compare groups. COVID-19, n = 66; pneumonia, n = 9. **, P < 0.01; *, P < 0.05. (C) GMI supports classification between COVID-19 and pneumonia control group.CC BY · PubMed Central
FIG 7 Genome-based microbiome signature enables distinction between COVID-19 subjects and heathy controls in an independent data set. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 MAGs. PERMANOVA test showed significant differences in the composition of the 33 MAGs between the two groups. (B) Significant differences in GMI and abundances of guilds 1 and 2 between COVID-19 and healthy subjects. Bar plot summarizes the mean and SEM. Mann-Whitney test (two-sided) was applied to compare groups. COVID-19, n = 46; healthy control, n = 19. *, P < 0.05; **, P < 0.01. (C) GMI supports classification of COVID-19 and healthy control subjects.
FIG 7 Genome-based microbiome signature enables distinction between COVID-19 subjects and heathy controls in an independent data set. (A) PCoA based on Bray-Curtis distance calculated from the abundance of the 33 MAGs. PERMANOVA test showed significant differences in the composition of the 33 MAGs between the two groups. (B) Significant differences in GMI and abundances of guilds 1 and 2 between COVID-19 and healthy subjects. Bar plot summarizes the mean and SEM. Mann-Whitney test (two-sided) was applied to compare groups. COVID-19, n = 46; healthy control, n = 19. *, P < 0.05; **, P < 0.01. (C) GMI supports classification of COVID-19 and healthy control subjects.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. 10.16288/j.yczz.20-080 · doi:10.16288/j.yczz.20-080 · Paper page

Cited by

See all 21

Metadata

Authors
Guo, M., Wu, G., Tan, Y., Li, Y., Jin, X., Qi, W., Guo, X., Zhang, C., Zhu, Z., & Zhao, L.
Affiliations
  • Shanghai Medical College of Fudan University (CN)
  • Rutgers, The State University of New Jersey (US)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Zhang, Chenhong
  • Zhu, Zhaoqin
  • Zhao, Liping
Venue
mBio
Published
2023-02-28
Volume
14
Issue
1
Pages
e0351922-e0351922
ISSN
2150-7511 (ISSN-L)
OpenAlex
W4319293583
Cited by
19
References
72
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 3
FWCI
1.69
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Shanghai Sailing Program (21YF1438800)
  • National Natural Science Foundation of China (8210061470)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
Keywords
COVID-19 pandemic, gut microbiota, microbial guilds, genome-resolved metagenomics, disease severity, prognosis, hospitalized patients, pneumonia, microbial interactions, microbiome signatures
MeSH terms
Gastrointestinal Microbiome, COVID-19, Feces, Humans, Prognosis, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis. https://app.cochat.ai/papers/10.1128/mbio.03519-22
The paper
Guo, M., Wu, G., Tan, Y., Li, Y., Jin, X., Qi, W., Guo, X., Zhang, C., Zhu, Z., & Zhao, L. (2023). Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis. mBio. https://doi.org/10.1128/mbio.03519-22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.